Community-Acquired Urinary Tract Infection by Escherichia coli in the Era of Antibiotic Resistance

• Published in: BioMed research international Vol. 2018; no. 2018; pp. 1 - 14
• Main Authors: Lee, Dong Sup, Choe, Hyun-Sop, Lee, Seung-Ju
• Format: Journal Article
• Language: English
• Published: Cairo, Egypt Hindawi Publishing Corporation 01.01.2018; Hindawi; John Wiley & Sons, Inc; Hindawi Limited
• Subjects: Animals; Anti-Bacterial Agents - therapeutic use; Antibiotic resistance; Antibiotics; Bacteria; Community; Community-Acquired Infections - drug therapy; Community-Acquired Infections - microbiology; Diabetes; Drug resistance; Drug resistance in microorganisms; Drug Resistance, Microbial - drug effects; E coli; Escherichia coli; Escherichia coli - drug effects; Escherichia coli Infections - drug therapy; Escherichia coli Infections - microbiology; Humans; Imipenem; Infections; Infectious diseases; Medical personnel; Microbial Sensitivity Tests - methods; Nitrofurantoin; Penicillin; Physicians; Review; Tazobactam; Urinary tract; Urinary Tract - drug effects; Urinary Tract - microbiology; Urinary tract diseases; Urinary tract infections; Urinary Tract Infections - drug therapy; Urinary Tract Infections - microbiology; Urogenital system; Urology; United Kingdom; India; Middle East; Turkey; Asia; United States > US; Europe; China; Japan; Italy; Australia; France; Spain
• ISSN: 2314-6133; 2314-6141
• DOI: 10.1155/2018/7656752

Urinary tract infections (UTIs) caused by Escherichia coli (E. coli) are the most common types of infections in women. The antibiotic resistance of E. coli is increasing rapidly, causing physicians to hesitate when selecting oral antibiotics. In this review, our objective is to ensure that clinicians understand the current seriousness of antibiotic-resistant E. coli, the mechanisms by which resistance is selected for, and methods that can be used to prevent antibiotic resistance.